Orbsen Therapeutics
@orbsentherapeutics.com
In the News Product Pipeline We are working on the development of an extensive range of therapies based on our proprietary technologies. The targets for these therapies include: Diabetic Foot Ulcers Acute Respiratory Distress Syndrome - ARDS Diabetic Kidney Disease - DKD
Orbsen Therapeutics's Company Logos
Orbsen Therapeutics's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#2C4398
Sapphire
44, 67, 152
227, 55, 38
71, 56, 0, 40
#33B5E5
Picton Blue
51, 181, 229
196, 77, 55
78, 21, 0, 10
#072C5E
Madison
7, 44, 94
214, 86, 20
93, 53, 0, 63
About Orbsen Therapeutics
Orbsen Therapeutics is a leading brand in the field of cell therapy, redefining the way we approach medical treatments. With a strong focus on innovation and research, they offer a range of groundbreaking therapies developed through their proprietary technologies. Their product pipeline includes therapies targeting a variety of conditions such as Diabetic Foot Ulcers, Acute Respiratory Distress Syndrome (ARDS), Diabetic Kidney Disease (DKD), and Primary Sclerosing Cholangitis (PSC).
These therapies have shown promising results in clinical studies and hold great potential for revolutionizing patient care in these areas. With their headquarters in Galway, Ireland, Orbsen Therapeutics is at the forefront of cutting-edge medical advancements. They have also launched the NEPHSTROM Clinical Trial at multiple locations in the European Union, further demonstrating their commitment to improving the lives of patients.
By continuously pushing the boundaries of medical science, Orbsen Therapeutics is paving the way for a brighter future in healthcare
Company type
Privately Held
Year founded
2006
Company size
11-50 employees
